跳至主要内容
临床试验/JPRN-UMIN000007362
JPRN-UMIN000007362已完成未知

An investigation of the serum uric acid-lowering effects of febuxostat in gout/hyperuricemia patients according to disease type - FORTUNE-2

Clinical research consortium on uric acid0 个研究点目标入组 100 人开始时间: 2012年2月23日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients who meet any of the 10 criteria below are ineligible for the study: 1) Patients who have a past history of hypersensitivity to febuxostat 2) Secondary hyperuricemia patients 3) Patients who have twice as high AST or ALT as the hospital's reference value 4) Males with serum creatinine level of 2.0 mg/dL or higher and females with serum creatinine level of 1.5 mg/dL or higher 5) Patients who have or have had past history of malignant tumor as a complication requiring treatment 6) Patients who are being treated with either mercaptopurine hydrate or azathioprine 7) Patients who are undergoing hormone replacement therapy (HRT) 8) Patients who are or are likely to become pregnant, and those who are lactating 9) Patients who participated in another clinical study or clinical trial in the six months prior to the confirmation of eligibility 10) Patients who the doctor in charge judges are ineligible for the study

研究者

发起方
Clinical research consortium on uric acid

相似试验